Accurate determination of prostate size via digital rectal examination and transrectal ultrasound

Urology

Volumn 51, Issue 4 SUPPL. A, 1998, Pages 19-22

  Roehrborn, Claus G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; AGED; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT SELECTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE DISEASE; RECTUM; SYMPTOMATOLOGY; TRANSRECTAL ULTRASONOGRAPHY; ULTRASOUND; URINE FLOW RATE;

EID: 0031980728     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00051-X     Document Type: Conference Paper

References (12)

1. Boyle P, Gould AL, Roehrborn CG. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride meta-analysis of randomized clinical trials . Urology. 48:1996;398-405.
2. McConnell JD, Barry MJ, Bruskewitz RC, Bueschen AJ, Denton SE, Holtgrewe HL, Lange JL, McClennan BL, Mebust WK, Reilly NJ, et al.: Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guideline, Number 8. AHCPR Publication No. 94-0582. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services. February 1994.
3. Rhodes T, Girman CJ, Jacobsen SJ, Guess IIA, Oesterling JE, Lieber MM. Longitudinal measures of prostate volume in a community sample - a 3 5-year follow-up in the Olmsted County study of urinary symptoms and health status among men . J Urol. 153:(Abstr.):1995;301A.
4. Girman CJ, Jacobsen SJ, Rhodes T, Guess HA, Lieber MM. Prostate size related to urinary symptoms and health-related quality of life in randomly selected men (Abstr ) . J Urol. 157:(suppl):1997;193.
5. Jacobsen SJ, Chute CG, Girman CJ, Oesterling JE, Guess HA, Lieber MM, Panser LA. Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men? Urology. 45:1995;64-69.
6. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM. Natural history of prostatism risk factors for acute urinary retention . J Urol. 158:1997;481-487.
7. Roehrborn CG, Girman CJ, Rhodes T, Hanson KA, Collins GN, Sech SM, Jacobsen SJ, Garraway WM, Lieber MM. Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology. 49:1997;548-557.
8. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism a population-based survey of urinary symptoms . J Urol. 150:1993;85-89.
9. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM. Serum prostate-specific antigen in a community-based population of healthy men establishment of age-specific reference ranges . JAMA. 270:1993;860-864.
10. Collins GN, Lee RJ, Russell EB, Raab GM, Hehir M. Ultrasonically determined patterns of enlargement in benign prostatic hyperplasia. Br J Urol. 71:1993;451-456.
11. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet. 338:1991;469-471.
12. Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, and Padley RJ, for the Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N Engl J Med 335: 533-539, 1996.